Carrus Capital Corporation is a Canada-based investment issuer. The Company is engaged in the identification and strategic investment in a diversified portfolio of public and private companies for capital growth. The Company also invests in the securities of companies, assets and businesses. The Company's investment objective is to increase shareholder value through the identification of and investment in securities of publicly listed corporations offering capital appreciation potential. The Company's subsidiaries include BioAB Strategies Ltd. (BioAB), BioDE Ventures Ltd. (BioDE) and BioHEP Technologies Ltd. (BioHEP). The biotechnology assets of its subsidiaries include Omigard and MX-226, CLS001, MX-2401 and MX-1313.